The "Global Regenerative Medicines Market - Analysis and Forecast (2017-2025) (Focus on Therapy, Applications, Market Share Analysis, 22 Country Analysis, and Competitive Landscape)" report has been added to ResearchAndMarkets.com's offering.

The regenerative medicines market generated $17.03 billion revenue in 2016 and is expected to reach $50.55 billion by 2025

The North America regenerative medicines market currently holds 39% percent of the global regenerative medicines market. Technological innovations across the various segments of the regenerative medicine have propelled growth in the recent past in the region.

The rapid expansion of the stem cell and gene therapy in the developed markets such as the U.S., Japan, Germany, and the U.K. is key driver for growth of regenerative medicines market.

As the world population is aging at a much faster pace, and the prevalence of diseases is rising, the demand is increasing for regenerative medicines that not only cure the chronic conditions completely but also improve the quality of life of the patients.

Other factors contributing to the growth of the regenerative medicine market include the rising awareness about regenerative medicine, technological advancements, and better efficacy, and safety provided by such products.

The major challenge to the growth of the market constitutes the changing regulatory environment. The stringent regulations implemented by the concerned regulatory bodies for the regenerative medicine products is a challenging factor for the industry players.

The global regenerative medicines market is generally dominated by the global orthopedic and wound biologics companies, however, depending on the geographical areas the market of these players varies accordingly. Efficient distribution networks, product differentiation and supply competency play a major role in determining the market position of such players.

Majority of these players are focusing on expanding distribution network as well as expanding presence, as Asia Pacific, Latin America and the Middle East are the developing regions and there is an increasing awareness about tissue and cell based products.

Key Topics Covered:

Executive Summary

1. Report Scope

2. Market Overview

3. Market Dynamics

4. Competitive Landscape

5. Global Regenerative Medicines Market, by Therapy

6. Global Regenerative Medicines Market, by Product (Qualitative)

7. Global Regenerative Medicines Market, by Application

8. Global Regenerative Medicines Market, by Region

9. Company Profiles

  • Acelity
  • Anika Therapeutics
  • Athersys, Inc.
  • Cook Biotech, Inc.
  • Capricor Therapeutics
  • Cellular Biomedicine Group, Inc.
  • Cytori Therapeutics
  • Gamida Cell
  • Integra Lifesciences Corporation
  • Juno Therapeutics
  • Mesoblast Limited
  • Mimedx Group Inc.
  • Novartis International Ag
  • Nuvasive, Inc.
  • Osiris Therapeutics, Inc.
  • Organogenesis Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Tigenix
  • Tissue Regenix
  • Vericel Corporation
  • Viacyte, Inc.
  • Zimmer Biomet Holdings Inc

For more information about this report visit https://www.researchandmarkets.com/research/bbszlm/global?w=4